A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

BACKGROUND: The most commonly applied treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a 5-day course of high-dose systemic corticosteroids. However, this treatment has not been shown to reduce mortality and can potentially have serious side effects. Recent rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivapalan, Pradeesh, Moberg, Mia, Eklöf, Josefin, Janner, Julie, Vestbo, Jørgen, Laub, Rasmus Rude, Browatzki, Andrea, Armbruster, Karin, Wilcke, Jon Torgny, Seersholm, Niels, Weinreich, Ulla Møller, Titlestad, Ingrid Louise, Andreassen, Helle Frost, Ulrik, Charlotte Suppli, Bødtger, Uffe, Nielsen, Thyge Lynghøj, Hansen, Ejvind Frausing, Jensen, Jens Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558695/
https://www.ncbi.nlm.nih.gov/pubmed/28810909
http://dx.doi.org/10.1186/s12890-017-0458-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558695/
https://www.ncbi.nlm.nih.gov/pubmed/28810909
http://dx.doi.org/10.1186/s12890-017-0458-7

Ejemplares similares